6.
Jaiswal A, Banerjee S, Aneja R, Sarkar F, Ostrov D, Narayan S
. DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer. PLoS One. 2011; 6(2):e16691.
PMC: 3032781.
DOI: 10.1371/journal.pone.0016691.
View
7.
Wallace S, Murphy D, Sweasy J
. Base excision repair and cancer. Cancer Lett. 2012; 327(1-2):73-89.
PMC: 3361536.
DOI: 10.1016/j.canlet.2011.12.038.
View
8.
Gordon M, Rosen L, Mendelson D, Ramanathan R, Goldman J, Liu L
. A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors. Invest New Drugs. 2012; 31(3):714-23.
PMC: 6662598.
DOI: 10.1007/s10637-012-9876-9.
View
9.
Kamble P, Hall K, Chandak M, Tang Q, Caglayan M
. DNA ligase I fidelity mediates the mutagenic ligation of pol β oxidized and mismatch nucleotide insertion products in base excision repair. J Biol Chem. 2021; 296:100427.
PMC: 8024709.
DOI: 10.1016/j.jbc.2021.100427.
View
10.
Lord C, Ashworth A
. PARP inhibitors: Synthetic lethality in the clinic. Science. 2017; 355(6330):1152-1158.
PMC: 6175050.
DOI: 10.1126/science.aam7344.
View
11.
Prasad R, Shock D, Beard W, Wilson S
. Substrate channeling in mammalian base excision repair pathways: passing the baton. J Biol Chem. 2010; 285(52):40479-88.
PMC: 3003346.
DOI: 10.1074/jbc.M110.155267.
View
12.
Caglayan M
. Interplay between DNA Polymerases and DNA Ligases: Influence on Substrate Channeling and the Fidelity of DNA Ligation. J Mol Biol. 2019; 431(11):2068-2081.
PMC: 6557440.
DOI: 10.1016/j.jmb.2019.04.028.
View
13.
Howes T, Tomkinson A
. DNA ligase I, the replicative DNA ligase. Subcell Biochem. 2012; 62:327-41.
PMC: 3881551.
DOI: 10.1007/978-94-007-4572-8_17.
View
14.
Tobin L, Robert C, Nagaria P, Chumsri S, Twaddell W, Ioffe O
. Targeting abnormal DNA repair in therapy-resistant breast cancers. Mol Cancer Res. 2011; 10(1):96-107.
PMC: 3319138.
DOI: 10.1158/1541-7786.MCR-11-0255.
View
15.
Liu Y, Prasad R, Beard W, Kedar P, Hou E, Shock D
. Coordination of steps in single-nucleotide base excision repair mediated by apurinic/apyrimidinic endonuclease 1 and DNA polymerase beta. J Biol Chem. 2007; 282(18):13532-41.
PMC: 2366199.
DOI: 10.1074/jbc.M611295200.
View
16.
Bai F, Morcos F, Cheng R, Jiang H, Onuchic J
. Elucidating the druggable interface of protein-protein interactions using fragment docking and coevolutionary analysis. Proc Natl Acad Sci U S A. 2016; 113(50):E8051-E8058.
PMC: 5167203.
DOI: 10.1073/pnas.1615932113.
View
17.
Tomkinson A, Howes T, Wiest N
. DNA ligases as therapeutic targets. Transl Cancer Res. 2013; 2(3).
PMC: 3819426.
View
18.
Caglayan M, Wilson S
. Oxidant and environmental toxicant-induced effects compromise DNA ligation during base excision DNA repair. DNA Repair (Amst). 2015; 35:85-9.
PMC: 4651769.
DOI: 10.1016/j.dnarep.2015.09.010.
View
19.
Sleeth K, Robson R, Dianov G
. Exchangeability of mammalian DNA ligases between base excision repair pathways. Biochemistry. 2004; 43(40):12924-30.
DOI: 10.1021/bi0492612.
View
20.
Lindahl T
. Keynote: past, present, and future aspects of base excision repair. Prog Nucleic Acid Res Mol Biol. 2001; 68:xvii-xxx.
DOI: 10.1016/s0079-6603(01)68084-x.
View